title: Response to letter: Duration of dual antiplatelet therapy following drug-eluting coronary stents: Longer or shorter?
authors.affiliation: Sussex Cardiac Centre, Brighton, UK. Electronic address: james.cockburn@bsuh.nhs.uk.
authors.forename: James
authors.initials: J
authors.lastname: Cockburn
authors.affiliation: Sussex Cardiac Centre, Brighton, UK.
authors.forename: David
authors.initials: D
authors.lastname: Hildick-Smith
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D003324:Coronary Artery Disease / Q000628:therapy*; D003328:Coronary Thrombosis / Q000517:prevention & control*; D054855:Drug-Eluting Stents / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D020123:Sirolimus / Q000031:analogs & derivatives*
chemical_list: D010975:Platelet Aggregation Inhibitors; D020123:Sirolimus